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Glucose degradation products (GDP) retard remesothelializa-
tion independently of D-glucose concentration.
Background. Glucose degradation products (GDP) present
in heat-sterilized dialysis fluids are thought to contribute to
cellular dysfunction and membrane damage during peritoneal
dialysis. To examine the effects of specific GDP on the remeso-
thelialization process, the impact of conventional and low GDP
peritoneal dialysis solutions, d-glucose, and individual GDP in
a scratch-wounding model was assessed.
Methods. Scratch (0.5 to 0.6 mm)-wounded human perito-
neal mesothelial cells (HPMC) were treated, at pH 7.4, with
either (1) control medium (M199), (2) laboratory-prepared
heat or filter-sterilized solutions, (3) 10% to 80% vol/vol solu-
tion of Gambrosol or Gambrosol-trio (1.5% and 4.0% glu-
cose), (4) d-glucose (5 to 80 mmol/L), or (5) individual or
combined GDP [acetaldehyde, formaldehyde, glyoxal, methyl-
glyoxal, 3-deoxyglucosone (3-DG), 5-hydroxy methylfufural
(5-HMF), or 3,4-di-deoxyglucosone-3-ene (3,4-DGE)]. Wound
closure was recorded by time-lapse photomicroscopy.
Results. In untreated HPMC, the rate of wound closure was
linear and the process was complete by 18.4  3.6 hours (N 
16). In wounded HPMC exposed to dilutions of heat-sterilized
but not filtered laboratory solutions (1.5% or 4.0% glucose,
pH 7.4), remesothelialization was significantly retarded (P 
0.04 and P  0.009 vs. M199, respectively). In Gambrosol,
remesothelialization was significantly retarded in both 1.5%
and 4.0% solutions. In contrast in Gambrosol-trio–treated
HPMC, this rate was not significantly reduced in either 1.5%
or 4.0% glucose peritoneal dialysis fluids. Remesothelialization
was dose-dependently retarded in HPMC exposed to 3,4-DGE
(10mol/L), formaldehyde (5mol/L) but not by exposure
to the other GDP tested even at 5 times the concentration
present in low glucose solutions. The rate of remesothelializa-
tion was not significantly altered by exposure to d-glucose
concentrations up to 80 mmol/L.
Conclusion. These data identify that the formaldehyde and
Key words: mesothelium, glucose degradation products, peritoneum,
formaldehyde, 3,4-di-deoxyglucosone-3-ene.
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3,4-DGE present in heat-sterilized peritoneal dialysis solu-
tions are important in reducing mesothelial cell regeneration.
Specifically targeting their removal may have major benefits
in preserving the mesothelium during long-term peritoneal
dialysis.
The mesothelial cells lining the peritoneal cavity play
a central role in maintaining peritoneal membrane integ-
rity and contributing to peritoneal host defense and ho-
meostasis [1]. During peritoneal dialysis, the mesothe-
lium is continuously exposed to unphysiologic peritoneal
dialysis fluids. Continuous mesothelial injury occurs as
evidenced by increased numbers of exfoliated cells pres-
ent in dialysis effluent, by decreased markers of mesothe-
lial cell mass in long-term peritoneal dialysis patients and
by recent evidence from the Biopsy Registry identifying
denudation in a large percentage of parietal peritoneal
samples [2, 3]. Mesothelial cell injury is exacerbated dur-
ing episodes of peritonitis [4, 5]. These data suggest that
continuous mesothelial cell turnover is a feature of the
dialyzed peritoneal cavity and that regeneration of these
cells is an important feature in maintaining membrane
integrity. Under normal conditions, the mesothelium has
the ability to repair damaged areas by a processes involv-
ing both cell proliferation, migration, and reseeding of
the denuded areas [6–9]. In vitro data suggest that re-
mesothelialization is regulated by a number of growth
factors, including epidermal growth factor (EGF), that
may be endogenously produced following cell injury
[10, 11]. These data are supported by evidence of the
ability of mesothelial cells to repair wounded areas in
the absence of exogenous growth factor addition [8].
There is now considerable evidence that components
of conventional heat-sterilized peritoneal dialysis fluids
can significantly modulate mesothelial cell function. While
low pH and high lactate concentrations have been shown
to reduce parameters of cell activation and viability,
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more recent data suggest that glucose concentrations,
hyperosmolality, and lactate may be important media-
tors of mesothelial cell activation contributing to profi-
brogenic and proinflammatory phenotype [12–17]. To
maintain sterility, conventional peritoneal dialysis solu-
tions are autoclaved and, although this process is per-
formed at acidic pH to prevent the caramelization of
glucose, it results in the formation of breakdown prod-
ucts of glucose whose concentrations also increase with
storage. Many of the glucose degradation products (GDP)
present in peritoneal dialysis fluids have now been identi-
fied and their biologic reactivity characterized in various
assay systems, including both acute- and chronic-expo-
sure models using mesothelial cells [18–21]. These data
suggest that individual GDP have different biologic ac-
tivities resulting in both inhibition and in some cases
activation of specific mesothelial cell functions, including
proliferation, cytokine and growth factor synthesis, and
cell viability [20, 22, 23]. In addition to their direct ability
to modulate cell function, their potential spectrum of
biologic activity is further enhanced by their ability to
contribute directly and rapidly to the process of ad-
vanced glycation end product (AGE) deposition [24, 25],
formation of which have been implicated in mesothelial
cell activation [26] and contributing to the morphologic
alterations in the peritoneal membrane [27, 28].
The identification of the potential deleterious impact
of GDP exposure has resulted in the development of
peritoneal dialysis fluids specifically engineered to re-
duce their concentrations [29–31]. These multicham-
bered bag systems allow glucose to be sterilized sepa-
rately from the other electrolytes at low pH (pH 3 to
4)) to reduce GDP formation to a minimum [32]. Clinical
studies using these “low GDP” solutions have identified
reduced impact on cell function and evidence of in-
creased mesothelial mass following their continuous use
[29, 31, 33, 34].
In the present study, we have examined the specific
impact of GDP on the endogenous remesothelialization
process following wounding. Our data suggest that at
clinically relevant concentrations (i.e., those present in
low glucose conventional heat-sterilized peritoneal dial-
ysis fluids) that formaldehyde and 3,4-di-deoxygluco-
sone-3-ene (3,4-DGE) impair the mesothelial cell repair,
independent of effects on cell viability or d-glucose con-
centration. These observations suggest that targeted re-
duction of specific GDP species may be important in
preserving mesothelial cell and peritoneal membrane in-
tegrity during long-term peritoneal dialysis.
METHODS
All chemicals, unless otherwise stated, were purchased
from Sigma-Aldrich, Ltd. (Poole, Dorset, UK). All tissue
culture plastics were Falcon, obtained from Becton
Dickinson Labware (Cowley, Oxford, UK).
Isolation and culture of human peritoneal
mesothelial cells
Human peritoneal mesothelial cells (HPMCs) were
isolated by enzymatic digestion of human omentum of
consenting patients undergoing abdominal surgery as
previously described [35, 36]. Cells were maintained in
Medium 199 (M199) containing 5 mmol/L d-glucose
(Gibco BRL, Life Technologies, Ltd., Paisley, Scotland)
containing 10% fetal calf serum (FCS) (Hyclone, Aalst,
Belgium) and supplemented with penicillin 100 U/mL,
streptomycin 100 g/mL, glutamine 2 mmol/L (Gibco
BRL, Life Technologies, Ltd.), insulin 5 g/mL, trans-
ferrin 5g/mL, and hydrocortisone 0.4g/mL. Confluent
cells were split at a ratio of 1:3 and second-passage cells
were used in all experiments. All solutions were free of
endotoxin as per manufacturers’ information.
Scratch wounding of HPMC monolayers
HPMC were grown to confluence in 24-well plates and
growth arrested for 48 hours in serum-free M199. HPMC
monolayers were wounded by a modification of the
method of Yung and Davies [8]. The monolayer was
wounded by a single gentle scrape with a sterile, 0.5 mm
diameter round sterile stainless steel rod without damag-
ing the base of the well. This resulted in a linear “wound”
of between 0.5 and 0.6 mm. The average diameter of the
wounded area was 0.55  0.06 mm (N  64 separate
wells). In cases where damage to the well was visible,
these were not used for data analysis. The monolayers
were then washed (with warm M199) to remove de-
tached cells and cellular debris before incubation with
test or control solutions for defined time periods up to
72 hours. Scratch wounding resulted in the removal of
4% of the HPMC monolayer from each well.
Assessment of remesothelialization by
time-lapse photomicroscopy
The denuded area in each well was identified micro-
scopically and the coordinates recorded for subsequent
data capture. Remesothelialization was continuously
monitored using an Axiovert 100M inverted microscope
fitted with a computer-controlled XY automated scan-
ning stage and incubator. The humidified incubator was
maintained at 37C and 5% CO2 with a heated insert and
vectorial airflow (Carl Zeiss, Oberkochen, Germany).
Images were captured from the same position in each
well of the 24-well plates, using the 2.5 objective, at
60-minute intervals on an Orca C5985 digital video cam-
era (Hamamatsu Photonics, Hamamatsu City, Japan).
Images were analyzed using Openlab version 3.0.8 on a
Macintosh G4 computer (Improvision, Ltd., Coventry,
UK). The rate of remesothelialization was calculated by
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measuring the reduction of the denuded area (in pixels)
at 60-minute intervals. Data are presented as m2/hour
for data converted from pixels following calibration of
the system with a graticule (Carl Zeiss).
Preparation of test solutions
Laboratory prepared fluids were of identical composi-
tion to standard solutions containing either 1.5% or 4.0%
d-glucose (Gambrosol) (Gambro, Lund, Sweden). These
solutions were either heat-sterilized (120C/20 minutes)
or filter-sterilized (0.2 filter) (Millipore, Watford UK).
d-glucose was obtained from Sigma-Aldrich, Ltd. All
solutions were stored at 4C and fresh aliquots were used
for each experiment. All solutions had endotoxin levels
below the detection limit as assessed by limulus ame-
bocyte lysate (LAL) assay (Sigma-Aldrich, Ltd.).
Commercially available solutions were either conven-
tional lactate-buffered, heat-sterilized fluids (Gambro-
sol) containing 1.5% or 4.0% dextrose or those manu-
factured in a triple-chambered bag (Gambrosol-trio)
(Gambro, Lund, Sweden) containing 1.5% or 4.0% dex-
trose. For experimental procedures, solutions were di-
luted to 10% to 80% (vol/vol) with M199 containing
2 mmol/L N-2-hydroxyethylpiperazine-N-2ethanesul-
fonic acid (HEPES) (to ensure that the pH was main-
tained at 7.4 throughout the experiment). All solutions
were at a pH of 7.4. d-glucose was diluted in M199/
HEPES (pH 7.4) and was used in HPMC exposure experi-
ments at a concentration range between 5 and 80 mmol/L.
Acetaldehyde, formaldehyde, methylglyoxal, and
5-hydroxy methylfufural (5-HMF) were purchased from
Sigma-Aldrich, Ltd. Glyoxal was purchased from Merck-
Eurolab (Stockholm, Sweden) and 3-deoxyglucosone
(3-DG) from Toronto Research Chemicals (Ottawa, Can-
ada). 3,4-di-deoxyglucosone-3-ene (3,4-DGE) was ex-
tracted from autoclaved glucose solutions using solid-
phase extraction (ENV-columns) (International Sorbent
Technologies, Pontypridd, UK) based on previously de-
scribed methods [37]. GDP were diluted from the stock
solutions in M199/HEPES (pH 7.4) and used in wounding
experiments either as a mixture of each of the tested
GDP (at the concentrations present in 1.5% heat-steri-
lized peritoneal dialysis fluids) or singly at concentrations
from one to five times those reported in commercially
available heat-sterilized 1.36% to 1.5% glucose-contain-
ing peritoneal dialysis fluids glyoxal (10 to 50 mol/L),
methylglyoxal (12 to 48 mol/L), acetaldehyde (0.1 to
0.5 mmol/L), 3,4-DGE (10 to 40 mol/L), formaldehyde
(5 to 50 mol/L), 3-DG (100 to 500 mol/L), and 5-HMF
(1 to 5 mol/L) [38–40].
Assessment of HPMC viability
HPMC viability was assessed 48 hours following wound-
ing measurement of intracellular adenosine triphosphate
(ATP) content as previously described [41].
Assessment of HPMC proliferation
HPMC cell numbers in wounding experiments were
assessed by 3-[4,5]dimethylthiazol-2,5-diphenyltetrazol-
ium bromide (MTT) assay as previously described [42].
Based on standard curves of increasing HPMC numbers
(103 to 105/well), there was a direct correlation between
HPMC numbers and MTT optical density (N  16, r 
0.998, P  0.001). Incubation of HPMC with different
test solutions did not affect MTT optical density (data
not shown).
Statistical analysis
All experiments were performed in 24-well plates with
random assignment of wells to different treatments. All
data are presented as mean [standard error of the mean
(SEM)] from five to nine experiments performed in qua-
druplicate with HPMC isolated from different omental
donors. Based on the nonnormal distribution of the data,
statistical analysis between two groups (wound areas at
the start and end of the observation period) was per-
formed using Wilcoxon signed rank test for related sam-
ples (SPSS version 10, SPSS, Inc., Chicago, IL, USA).
Differences were considered significant when P  0.05.
RESULTS
Remesothelialization of HPMC
As in previous experiments in 35 mm dishes [8], when
confluent HPMC were wounded (0.5 to 0.75mm scratch)
in 24-well plates, complete remesothelialization occurred
under serum-free conditions and appeared to be depen-
dent on cell migration (as evidenced by no significant
increases in MTT values). In these experiments, remeso-
thelialization was linear for the first 12 to 15 hours of the
experiment and wound closure was found to be complete
within 18.4  3.6 hours (N  16) (Fig. 1). The linearity
of the remesothelialization response was maintained re-
gardless of treatment and was only significantly disrupted
in the face of significant loss of cell viability. The rate
of remesothelialization under serum-free conditions in
M199 was median 33.3 (range, 18.6 to 50.7) m2/hour
(N  16 different cell lines).
Remesothelialization following exposure to
laboratory-prepared fluids
In order to examine the importance of GDP in modu-
lating remesothelialization, laboratory-prepared perito-
neal dialysis fluids were prepared and either heat- or
filter- sterilized. In order to minimize the impact of cell
viability in the remesothelialization experiments, prelim-
inary viability experiments (in confluent HPMC) were
performed. These identified that dilution of all test solu-
tions 1:4 (25%vol/vol) in M199 avoided significant loss
of monolayer viability over a 24-hour period [as assessed
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Fig. 1. Time course of remesothelialisation (A ) and time-lapse photography (B ) following scratch wounding in human peritoneal mesothelial
cells (HPMC) exposed to control medium (M199). Data presented are the mean wound areas (  SEM) at the indicated time points from 16
experiments . Wound healing rate is calculated over the first 12 hours postwounding from the gradient of the line; median rate 33.3 (range, 18.6 to
50.7) m/hour (N  16 different cell lines). Time-lapse photographs demonstrate linear wound closure accompanied by migration of phenotypically
altered cells into the denuded area prior to complete closure by between 10 and 15 hours (representative pictures presented).
by total ATP measurement (data not shown)]. A 25%
vol/vol dilution was subsequently used in all HPMC
wounding experiments in which laboratory-prepared or
commercial dialysis solutions were used.
Exposure of scratch-wounded HPMC to heat-steri-
lized laboratory-prepared peritoneal dialysis fluids re-
sulted in a significant retardation or failure of remeso-
thelialization (8.8 4.4 m2/hour and	10.6 4.43 m2/
hour for 1.5% and 4.0% d-glucose peritoneal dialysis
fluids, respectively) (N  5; P  0.04 and P  0.009 vs.
M199) (Fig. 2A). In contrast, in wounded HPMC ex-
posed to filter-sterilized peritoneal dialysis fluids, re-
mesothelialization proceeded at a normal rate in both
1.5% (24 3.6 m2/hour) and 4.0% (32 1.5 m2/hour)
and M199 (28  3.0 m2/hour), respectively) (N  6;
P  NS for both vs. M199) (Fig. 2A).
Assessment of cell numbers by MTT assay showed a
significant reduction (N 6; P 0.04 for both) in HPMC
treated with heat-sterilized fluids compared to filtered
fluids and to controls (M199) at the conclusion of the
experiment (72 hours) (Fig. 2B).
Remesothelialization following exposure to
commercial peritoneal dialysis fluids
Wounded HPMC exposed to 25% vol/vol conven-
tional lactate-buffered peritoneal dialysis fluids (Gam-
brosol) of both high and low glucose content showed
complete retardation in remesothelialization in both
1.5% and 4.0% Gambrosol (N  6; P  0.04 and P 
0.02 vs. M199, respectively) (Fig. 3A). In Gambrosol-
trio, however, the remesothelialization rate was not
different to M199 (34  3.2 m2/hour, 25.2  9.4 m2/
hour, and 28.1  3.6 m2/hour for 1.5% Gambrosol-
trio, 4.0% Gambrosol-trio, and M199, respectively)
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Fig. 2. Time course of remesothelialization
(A ) and cell numbers (B ) following scratch
wounding in human peritoneal mesothelial
cells (HPMC) exposed to heat-sterilized (HS)
and sterile-filtered (SF) laboratory-prepared
dialysis solutions and control medium (M199).
Data presented are the mean (N  6 separate
experiments performed in quadruplicates)
changes in wound areas at the indicated time
points in HPMC exposed to 25% vol/vol dilu-
tions of the test and control (M199) solutions.
The rate of remesothelialization was signifi-
cantly retarded in both 1.5% HS and 4.0% HS
compared to M199 (N  6; P  0.04 and P 
0.009, respectively, Wilcoxon signed ranks test).
Remesothelialization rate was unaffected by
exposure to sterile filtered solutions. At the
conclusion of the experiment (72 hours), cell
numbers were assessed by 3-[4,5]dimethylthia-
zol-2,5-diphenyltetrazolium bromide (MTT)
assay and were significantly reduced compared
to M199 in both 1.5% and 4.0% heat-sterilized
solutions (P  0.05 for both) (B).
(Fig. 3A). The complete retardation of remesothelializa-
tion in Gambrosol was in each case associated with
significant reductions in HPMC viability and disruption
of the monolayer as assessed by total ATP content (Fig. 3B)
and direct visualization (Fig. 3C). Cell viability and re-
mesothelialization remained unaffected in Gambrosol-
trio, regardless of glucose concentration (Fig. 3B).
In order to demonstrate the specificity of the observed
effects on remesothelialization in subsequent experi-
ments, wounded HPMC were exposed to decreasing di-
lutions of commercial peritoneal dialysis fluids (10% to
80% vol/vol) in M199. Regardless of dilution or glucose
concentration, exposure of wounded HPMC to Gambro-
sol-trio was not associated with significant alterations
in the rate of remesothelialization [1.5% Gambrosol-
trio (80% vol/vol) 22.7  2.7 m2/hour vs. M199 29.7 
2.3 m2/hour (N  5, P  NS)] or reductions in cell
viability (data not shown) (Fig. 4C and D). In contrast,
exposure of wounded HPMC to Gambrosol was associ-
ated with a dose-dependent retardation of remesotheli-
alization (Fig. 4A and B). At dilution of 1.5% and 4.0%
solutions above 10%vol/vol, the remesothelialization
process was significantly retarded and was prevented at
dilutions above 25% vol/vol (11.7  1.2 m2/hour) and
20% vol/vol (	7.0  6 m2/hour) for Gambrosol 1.5%
and 4.0%, respectively (N  5, P  0.05 for all) (Fig.
4 A and B). Concentrations above 50% vol/vol and 30%
vol/vol for 1.5% and 4.0% Gambrosol, respectively,
were associated with reductions in HPMC viability (data
not shown).
Impact of D-glucose on remesothelialization
The above data were suggestive of little impact of
d-glucose per se on the process of remesothelialization.
To confirm these observations, a series of d-glucose solu-
tions (5 to 80 mmol/L) were prepared in M199/HEPES
at pH 7.4. Exposure of wounded HPMC to solutions
containing increasing concentrations of glucose was not
associated with significant retardation of remesotheliali-
zation, regardless of glucose concentration (M199, 46.1
6.8 m2/hour; 80 mmol/L d-glucose, 37.5  5.58 m2/
hour) (Fig. 5A and C). HPMC viability was not signifi-
cantly affected by exposure to glucose concentrations up
to 80 mmol/L (Fig. 5B) nor was there any difference in
cell number as assessed by MTT staining (data not shown).
Remesothelialization in the presence of specific GDP
To identify which GDP species were responsible for
specific effects in retarding remesothelialization, wounded
HPMC were exposed to individual GDP species at con-
centrations five times that detected in commercial 1.5%
peritoneal dialysis fluids. Attenuation of remesotheliali-
zation was only observed in wounded HPMC exposed
to formaldehyde and 3,4-DGE (N  6, P  0.005 for
both), whereas the other GDP species had no effect on
the healing process (Fig. 6A).
Remesothelialization in the presence of
mixtures of GDP
To further confirm these observations on the specific
effects of formaldehyde and 3,4-DGE and to examine
if additive effects were evident, a subsequent series of
experiments compared the responses of these GDP spe-
cies singly (1 concentration, 5 mol/L and 10 mol/L
formaldehyde and 3,4-DGE, respectively), with a combi-
nation of each at these same concentrations and a cock-
tail of all of the GDP (glyoxal, methylglyoxal, 5-HMF,
acetaldehyde, formaldehyde, 3,4-DGE, and 3-DG) at
the concentrations found in 1.5% heat-sterilized perito-
neal dialysis fluids (1 mix). Both 1 formaldehyde
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Fig. 3. Time course of remesothelialization (A ), viability (B ), and time-lapse photography (C ) following scratch wounding in human peritoneal
mesothelial cells (HPMC) exposed to Gambrosol (G) (1.5% and 4.0%), Gambrosol-trio (Trio) (1.5% and 4.0%) or to control medium (M199).
Data are the mean (N  6 separate experiments performed in quadruplicate) wound areas at the indicated time points in HPMC exposed to 25%
vol/vol dilutions of the test solutions or to M199. The rate of remesothelialization was significantly retarded in both Gambrosol (1.5% and 4.0%)
solutions compared to M199 (N  6; P  0.04 and P  0.02, respectively, Wilcoxon signed ranks test. Remesothelialization rate was unaffected
by exposure to Gambrosol-trio (1.5% and 4.0%). At the conclusion of the experiment (72 hours), cell viability was assessed by measuring total
cellular adenosine tri phosphate (ATP), which was significantly reduced (compared to M199) in both Gambrosol (1.5% and 4.0%) solutions
(N  6; P  0.05 for both) (B). Time-lapse photographs demonstrate the failure of wound closure in HPMC exposed to Gambrosol (1.5% and
4.0%) but complete closure by between 10 and 15 hours in HPMC exposed to Gambrosol-trio (1.5% and 4.0%) solutions (representative pictures
are presented).
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Fig. 4. Time course of remesothelialization
following scratch wounding in human perito-
neal mesothelial cells (HPMC) exposed to in-
creasing dilutions (10% to 50% vol/vol) of
Gambrosol (1.5% and 4.0%) (A and B ) and
(40% to 80% vol/vol) Gambrosol-trio (1.5%
and 4.0%) (C and D ) or to M199. Data are
the mean wound areas at the indicated time
points in HPMC exposed to test solutions or
to M199. The rate of remesothelialization was
significantly retarded in all Gambrosol (1.5%
and 4.0%) solutions above 10% vol/vol com-
pared to M199 (N  6; P  0.05 for all Wil-
coxon signed ranks test). The rate of remeso-
thelialization was not retarded at any of the
dilutions of Gambrosol-trio (1.5% and 4.0%).
and 3,4-DGE significantly retarded remesothelialization
(16  3.6 m2/hour and 21  4.2 m2/hour vs. 34 
3.2 m2/hour for M199) (N  5, P  0.04 for both).
The combination of 1 formaldehyde and 1 3,4-DGE
resulted in a further reduction of the rate of closure
(11.4  1.75 m2/hour) (N  5, P  0.05 vs. M199)
that was similar to that observed in the complete GDP
cocktail (10  4 m2/hour) (N  5, P  0.02 for both vs.
M199) (Fig. 6B). Cell viability was not reduced following
exposure to 5 glyoxal, methylglyoxal, 3-DG, 5-HMF,
or acetaldehyde to the mixtures of formaldehyde and
3,4-DGE (1) or to the mixture of all GDP (1 mix)
(data not shown).
To confirm these observations, wounded HPMC were
exposed to increasing concentrations of formaldehyde
and 3,4-DGE. In these experiments, both 3,4-DGE and
formaldehyde dose-dependently attenuated the remeso-
thelialization process (Fig. 7A and C). Cell viability was
only significantly reduced at concentrations of 3,4-DGE
above 30mol/L (3) and formaldehyde above 15mol/L
(3) (Fig. 7B and C).
DISCUSSION
In the current study, we have utilized a well-character-
ized model of remesothelialization to examine the im-
pact of GDP-containing solutions on the process of meso-
thelial cell regeneration following injury [8, 9]. These
experiments have specifically examined the effect of
GDP in the absence of effects of pH, loss of cell viability,
or the confounding effects of growth factor–rich FCS.
The data indicate that the endogenous process of meso-
thelial cell repair is specifically retarded by GDP spe-
cies and appears to be independent of specific effects of
d-glucose at the concentrations present in low glucose
peritoneal dialysis fluids.
Interest in the importance of GDP as potentially bioin-
compatible components of commercial peritoneal dial-
ysis fluids stems from the early observation that infusion
pain in patients on peritoneal dialysis was increased
when fluids had been stored for a greater length of time
[43]. The high concentrations of glucose in peritoneal
dialysis fluids decompose spontaneously during storage,
but this decomposition process is accelerated by heat
sterilization and results in the formation of de novo deg-
radation products of glucose [44, 45]. Subsequent investi-
gations using a range of in vitro test systems have not
only identified many of the specific GDP species but also
identified that, either in combination (as occurs in heat-
sterilized peritoneal dialysis fluids) or singly, these reac-
tive aldehydes and carbonyls have significant capacity to
modulate cell viability and function both in vitro and in
vivo [19, 20, 22, 23, 46, 47].
Although initial experiments characterizing the global
impact of GDP concentrated predominantly on the
mouse L929 fibroblast system [19], more recently the
mesothelium, the primary target of peritoneal dialysis
fluid effects in the peritoneal cavity, has become the test
system of choice. Interestingly, these cells appear to be
even more susceptible to GDP-mediated effects that the
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Fig. 5. Time course of remesothelialization (A ), viability (B ), and time-lapse photography (C ) following scratch wounding in human peritoneal
mesothelial cells (HPMC) exposed to increasing concentrations (10 to 80 mmol/L) of D-glucose or to control medium (M199). Data are the mean
(N  6 separate experiments performed in quadruplicate) wound areas at the indicated time points. Neither the rate of remesothelialization (A)
nor cell viability [adenosine triphosphate (ATP) assay] (B) was significantly affected by exposure to d-glucose. Representative time-lapse video
images (C) of the remesothelialization process in d-glucose (80 mmol/L) and M199.
transformed L929 cell line [23]. While these initial obser-
vations were important in defining the increased sensitiv-
ity of mesothelial cells to combined and individual GDP-
mediated effects, in general, for significant modulation
of biologic effects (cytokine and growth factor release
and cell viability) to occur, individual GDP needed to
be used at concentrations well above those found in high
glucose peritoneal dialysis fluids [21–23, 48]. Although
these results may be partly explained by the volatility
and reactivity of GDP, resulting in lower effective con-
centrations than those originally added to the test system,
they do not mimic the significant modulation of cellular
function attributed to the presence of GDP in heat-steri-
lized peritoneal dialysis fluids [19]. Nevertheless, these
data provided pointers to the differences in individual
GDP biologic reactivity [23].
In more relevant experiments, Witowski et al [20] have
chronically exposed mesothelial cell monolayers to a
mixture of GDP at the maximum concentrations present
in 4.0% glucose solutions. These experiments, although
unequivocally showing specific GDP-mediated effects on
cell function [cell proliferation and interleukin-6 (IL-6)
synthesis], were associated with time-dependent loss of
cell viability (approximately 75% reduction) and loss of
monolayer integrity (although the cells remaining after
36 days showed normal cell proliferation when converted
to new GDP free-serum–containing medium).
In the current study, we have attempted to identify spe-
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Fig. 6. Time course of remesothelialization following scratch wounding in human peritoneal mesothelial cells (HPMC) exposed to individual
glucose degradation products (GDP) [formaldehyde (FoA), 3,4-di-deoxyglucosone-3-ene (3,4-DGE), acetaldehyde (AcA), glyoxal (GO), methylgly-
oxal (MGO), 5-hydroxy methylfufural (5-HMF), and 3-deoxyglucosone (3-DG)] at five times the concentrations present in 1.5% glucose peritoneal
dialysis fluids (A ) or to either a mixture of FoA, 3,4-DGE, GO, MGO, 5-HMF, 3-DG FoA, 3,4-DGE, and AcA (1 mix) at the concentrations
present in 1.5% heat-sterilized peritoneal dialysis fluids or singly to FoA and 3,4-DGE at the concentrations present in 1.5% heat-sterilized
peritoneal dialysis fluids or to a combination of FoA and 3,4-DGE (B ). Data are the mean (N  5 separate experiments) wound areas at the
indicated time points. The rate of remesothelialization was significantly retarded in 5 and 1 FoA, 1 3,4-DGE, the combination of FoA and
3,4-DGE and the 1 mix compared to M199 (N  5; P values as indicated, Wilcoxon signed ranks test.
Fig. 7. Time course of remesothelialization
(A and C ) and viability (B and D ) following
scratch wounding in human peritoneal meso-
thelial cells (HPMC) exposed to increasing
concentrations (1-5) of formaldehyde (FoA)
and 3,4-di-deoxyglucosone-3-ene (3,4-DGE).
Data are the mean (N  5 separate experi-
ments) wound areas at the indicated time
points. The rate of remesothelialization was
significantly retarded at all concentrations of
FoA (A) and 3,4-DGE (C) compared to M199
(N  5). *P  0.05; **P  0.02 Wilcoxon
signed ranks test. Cell viability as assessed by
total adenosine triphosphate (ATP) concen-
tration was significantly reduced by both 5
FoA and 3,4-DGE compared to M199 (N 
5; P 0.04 for all Wilcoxon signed ranks test).
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cific GDP-mediated effects (to include those of the re-
cently described 3,4-DGE) on the process of remesothe-
lialization at concentrations relevant to the majority of
peritoneal dialysis exposure (i.e., 1.5% glucose solutions)
and in the absence of a significant effect on cell viability.
Although initial experiments with heat-sterilized labora-
tory and commercial solutions (diluted 1:4 following pre-
viously published protocols and preliminary viability as-
sessments in monolayer cultures) showed inhibition of
remesothelialization, these effects were in wounded cells
clearly influenced by loss of mesothelial cell viability.
These data identify once again the extreme sensitivity
of cultured mesothelial cells to dialysis fluid and GDP-
mediated effects but also that extrapolation from mono-
layer to wounded systems needs to be interpreted with
caution as the latter appears to be more sensitive to the
cytotoxic effects of peritoneal dialysis fluids. The magni-
tude of effect in these dialysis fluid experiments, com-
pared to the individual and combined GDP effects (see
later), clearly identifies, however, that it is the combina-
tion of GDP in commercial solutions that mediates the
most significant biologic effects and/or that other dialysis
solution components or combinations thereof contribute
to the observed modulation of cell behavior. In this re-
spect, both individual and combined effects of other dial-
ysis fluid components, including osmolality, glucose, and
lactate concentration have been observed in several cell
systems [12–15, 49]. To date, however, whether these
synergize with GDP in modulating cell function has not
been studied. In the majority of previous studies aimed at
identifying specific GDP effects, individual or combined
levels either at or above those in (3.86% to 4.5%) have
been used. Interestingly, the effects observed in our re-
mesothelialization system with conventional heat-steri-
lized solutions were manifested at GDP concentrations
below those present in low glucose peritoneal dialysis
fluids (since both 1.5% and 4.0% solutions were diluted
1:4 for these experiments). These observations confirm
both the sensitivity of the test system (see earlier) and
the fact that the combinations of GDP (many of which
remain to be identified) present even in conventional
low glucose peritoneal dialysis fluids are likely to have
relevant biologic effects within the peritoneal cavity in
vivo. That exposure of the peritoneal cavity to such low
concentrations of GDP is more relevant to the in vivo
situation is emphasized by recently published data docu-
menting their rapid disappearance or sequestration from
the dialyzed peritoneal cavity and their contribution to
systemic AGE formation [50].
Cumulative exposure to dialysis fluid glucose has pre-
viously been implicated as a major causative factor in
both functional and structural changes in the dialyzed
peritoneum [3, 51]. Although data on mesothelial cell
proliferation and activation has implicated d-glucose in
mediating cell activation mediated by protein kinase C
(PKC) and polyol pathway activation [12–15, 52], the
data from the current study suggest that glucose per se
has little direct effect in modulating the remesothelializa-
tion process. In our remesothelialization experiments,
d-glucose at concentrations relevant to 1.5% (up to 80
mmol/L) peritoneal dialysis fluids had no significant ef-
fect on remesothelialization or cell viability. These data
suggest that the effects observed following exposure of
mesothelial cells to peritoneal dialysis fluids are GDP
specific. Given that previous studies have identified that
increased cell migration and cell proliferation control
this process, these data suggest that GDP may have spe-
cific effects on both these processes [8–11]. In this re-
spect, GDP exposure has been previously shown to have
direct effects on L929 and mesothelial cell proliferation
[19, 20, 23].
That significant effects attributable to GDP content
in the absence of significant effects on cell viability were
further demonstrated in experiments using serial dilu-
tions of commercial high and low GDP solutions in which
significant effects were only seen with conventional heat-
sterilized peritoneal dialysis fluids (Gambrosol), whereas
low GDP solutions (Gambrosol-trio) did not retard the
remesothelialization process. These data parallel recent
observations using intravital microscopy of mesenteric
vessels in which the retardation of leukocyte rolling and
margination as a result of exposure to GDP containing
peritoneal dialysis fluid was significantly reduced with
low GDP solutions [47].
Based on the hypothesis that individual GDP species
would have less effect than combined exposure (c.f., the
dialysis solution experiments), initial experiments ex-
posed wounded mesothelial cells to concentrations of
individual GDP at five times the concentration present
in low glucose solutions. The majority of the GDP tested
were without effect on remesothelialization or cell via-
bility. While it is well established that 5-HMF (although
used as a marker of overall glucose degradation) has lit-
tle biologic effect in test systems, other GDP species,
including acetaldehyde, glyoxal, and methylglyoxal, have
been shown to modulate mesothelial cell and endothelial
cell function and viability [20, 22, 23]. In these experi-
ments, however, individual or combined GDP exposure
protocols used much higher concentrations than in the
current study to obtain significant effects, that in many
cases were associated with significant loss of cell viability.
Only two of the GDP species tested, formaldehyde
and the recently described dicarbonyl 3,4-DGE, had a
significant effect on the process, although this was clearly
the result of direct cell cytotoxicity in these initial experi-
ments [37, 53]. Subsequent experiments demonstrated
that the effects of formaldehyde and 3,4-DGE on the
remesothelialization were dose-dependent, with signifi-
cant retardation of the process without effects on cell
viability occurring at concentrations relevant to those
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present in 1.5% conventional peritoneal dialysis fluids.
These data concur with previous studies in HPMC mono-
layer cultures that have suggested that formaldehyde is
one of the most toxic GDP species [23]. Data on the
biologic actions of 3,4-DGE have only recently emerged.
This compound, originally isolated from Sargassum jell-
manianum (a brown seaweed), has been shown to have
effects (at concentrations relevant to those present in
peritoneal dialysis fluids, 9.1 to 18.3 mol/L) on macro-
phage and T-cell proliferation, B-cell antibody produc-
tion, and more recently to be the most biologically active
GDP in the L929 fibroblast proliferation system [53].
The precise mechanisms by which these two GDP species
modulate mesothelial cell behavior in the absence of
effects on cell viability is not known. It is tempting to
speculate, however, that these reactive intermediates in
some way modulate the processes of migration and pro-
liferation important in the remesothelialization process
[8–11]. These types of effect may be particularly relevant
to 3,4-DGE that has been shown previously to modulate
macrophage and T-cell proliferation [53]. In addition,
the effects on mesothelial cell function may be secondary
to AGE formation, known to be accelerated by the pres-
ence of GDP [54]. Interestingly, the concentration of
3,4-DGE appears to increase with storage and is an inter-
mediate in the Maillard reaction [53]. Although glucose
has the ability to bind nonenzymatically to free amino
groups on proteins, resulting in the formation of AGE,
it is now well established that glycation mediated directly
by GDP may be of equal importance in AGE formation
[24, 25, 55]. AGE have been detected in the mesothe-
lium, submesothelial stroma, and vascular walls of peri-
toneal dialysis patients and correlate with histopatho-
logic changes in the dialyzed peritoneal membrane
[27, 28]. Recently, AGE adducts have been implicated
indirectly in mesothelial cell and endothelial cell activa-
tion and the induction of vascular endothelial growth
factor (VEGF) [26]. Taken together, these data add to
the spectrum of detrimental activity of GDP in the peri-
toneal cavity.
The combination of GDP do, however, appear to be
important in modulating mesothelial cell function. In the
current experiments, GDP, when applied in combina-
tions (as the cocktail found in 1.5% peritoneal dialy-
sis fluids or following addition of formaldehyde and
3,4-DGE), achieved a greater degree of inhibition of re-
mesothelialization than when applied individually. These
data concur with previous observations that the maxi-
mum effect in any of the biologic assays used to test
GDP activity is always mediated by conventional heat-
sterilized peritoneal dialysis fluids, emphasizing that the
interplay between solution components and GDP spe-
cies contributes to the overall effects in modulating cell
function.
CONCLUSION
The present study has demonstrated that concentra-
tions of GDP relevant to the majority of dialysis dwells
significantly modulate remesothelialization by a process
that does not necessarily involve a reduction in cell via-
bility. These effects on remesothelialization appear to
be mediated primarily by the combination of 3,4-DGE
and formaldehyde. Although the mechanisms by which
these effects occur are unknown, the dependence of the
remesothelialization process on cell migration and cell
proliferation suggests that these may be one of the pri-
mary targets of GDP action. Considerable clinical inter-
est has been generated in the use of more biocompatible
peritoneal dialysis fluids since data from short-term clini-
cal trials has demonstrated that conversion of patients
from standard heat-sterilized acidic lactate-buffered
peritoneal dialysis fluids containing glucose to potentially
more “biocompatible solutions” of neutral or physiologic
pH and containing reduced GDP levels have been associ-
ated with positive impact on ex vivo cell function, evi-
dence of increased mesothelial cell preservation [29, 31,
33, 34], and recent data on reduced systemic AGE for-
mation [50]. The current observations suggest that solu-
tion GDP content might contribute to retarding normal
mesothelial turnover in long-term peritoneal dialysis.
Recent developments in solution design have concen-
trated on the overall reduction in GDP profile, the cur-
rent data suggest that targeting the reduction of 3,4-DGE
and formaldehyde in particular may best achieve the
goal of mesothelial cell and membrane preservation in
long-term peritoneal dialysis.
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